SCHEMBL5089563

SCHEMBL5089563

CCCCC#C/C=C\C#Cc1ccccc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 1/20 0.40
CYP1A2 P05177 3/20 0.38
CYP3A4 P08684 3/20 0.38
CYP2C19 P33261 3/20 0.38
CYP2C9 P11712 2/20 0.38
THPO P40225 1/20 0.38
APP P05067 1/20 0.38
BLM P54132 1/20 0.37
PMP22 Q01453 1/20 0.37
FFAR1 O14842 1/20 0.37
FFAR4 Q5NUL3 1/20 0.37
HTR2A P28223 1/20 0.37
MAPT P10636 3/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
KDM4E B2RXH2 1/20 0.37
LMNA P02545 1/20 0.37
CYP2D6 P10635 1/20 0.37
APEX1 P27695 1/20 0.37
HSD17B10 Q99714 1/20 0.37
TDP1 Q9NUW8 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5089568 1.00 NPSR1 (0.40) NPSR1CYP1A2CYP3A4CYP2C19CYP2C9
SCHEMBL5089559 1.00 NPSR1 (0.40) NPSR1CYP1A2CYP3A4CYP2C19CYP2C9
SCHEMBL5095231 0.86 FFAR1 (0.37) CYP1A2CYP3A4CYP2C19FFAR1FFAR4
SCHEMBL5095230 0.86 FFAR1 (0.37) CYP1A2CYP3A4CYP2C19FFAR1FFAR4
SCHEMBL5092657 0.84 FFAR1 (0.48) CYP3A4FFAR1FFAR4KCNH2MMP2
SCHEMBL5092667 0.84 FFAR1 (0.48) CYP3A4FFAR1FFAR4KCNH2MMP2
SCHEMBL614578 0.83 CYP1A2 (0.50) NPSR1CYP1A2CYP3A4CYP2C19CYP2C9
Hydrochloric Acid SCHEMBL31144511 0.81 BLM (0.52) NPSR1CYP1A2CYP3A4CYP2C19CYP2C9
SCHEMBL5089564 0.79 NPSR1 (0.47) NPSR1CYP1A2CYP3A4CYP2C19CYP2C9
SCHEMBL5095343 0.79 FFAR1 (0.44) CYP1A2CYP3A4CYP2C19CYP2C9FFAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7332623-B2 Aryl-substituted acyclic enediyne compounds KAOHSIUNG MEDICAL UNIVERSITY (TW) 2008-02-19 US disclosed
US-20050004212-A1 Aryl-substituted acyclic enediyne compounds KAOHSIUNG MEDICAL UNIVERSITY 2005-01-06 US disclosed
US-20050004211-A1 Pharmaceutical compositions comprising aryl-substituted acyclic enediyne compounds KAOHSIUNG MEDICAL UNIVERSITY 2005-01-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050004211-A1 Pharmaceutical compositions comprising aryl-substituted acyclic enediyne compounds CCNI, TOP1, TOP2B NPSR1 1932/4885CYP1A2 436/4885CYP3A4 542/4885
US-20050004212-A1 Aryl-substituted acyclic enediyne compounds CCNI, TOP2B, TOP2A NPSR1 1557/4885CYP1A2 777/4885CYP3A4 1065/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.